A new model for non-typeable Haemophilus influenzae middle ear infection in the Junbo mutant mouse

Derek Hood1, Richard Moxon2, Tom Purnell1

  • 1MRC Mammalian Genetics Unit, MRC Harwell, Didcot, Oxford, OX11 0RD, UK.

Disease Models & Mechanisms
|November 28, 2015
PubMed

Insights

A new Junbo mouse model effectively mimics childhood middle ear infections caused by non-typeable Haemophilus influenzae (NTHi). This model aids in testing new vaccines and antimicrobial treatments for NTHi otitis media.

Area of Science:

  • Microbiology
  • Immunology
  • Otolaryngology

Background:

  • Acute otitis media is a common childhood infection and a primary reason for antibiotic prescriptions.
  • Non-typeable Haemophilus influenzae (NTHi) is a key pathogen in otitis media, lacking an effective vaccine.
  • Existing animal models for middle ear infections have limitations.

Purpose of the Study:

  • To establish and validate a robust mouse model for NTHi-induced otitis media.
  • To assess the translational potential of this model for evaluating antimicrobial therapies and vaccine efficacy.

Main Methods:

  • Utilized the Junbo mouse model (Jbo/+), which exhibits spontaneous chronic middle ear inflammation.
  • Administered a single intranasal inoculation of NTHi to induce middle ear infections.
  • Monitored infection rates, bacterial titers, and host immune responses (cytokine gene expression).
  • Evaluated the efficacy of azithromycin treatment and a killed NTHi vaccine in the model.

Main Results:

  • The Junbo mouse model demonstrated high infection rates (up to 90%) and bacterial loads following NTHi inoculation.
  • Bacterial clearance occurred in most mice between days 21-35, with persistence in some up to day 56.
  • Elevated expression of Toll-like receptor-dependent cytokine genes was observed in infected middle ears.
  • Azithromycin treatment successfully cleared NTHi, and immunization with killed homologous NTHi provided protection.

Conclusions:

  • The Junbo mouse model is a viable and robust platform for studying NTHi middle ear infections.
  • This model shows significant translational potential for preclinical testing of antimicrobial regimens and vaccine candidates against NTHi otitis media.

Related Concept Videos